NEW YORK, Feb 6 – Deltagen said Tuesday its fourth quarter revenue shot up to $1.3 million, compared with $318,000 in the corresponding quarter last year, while revenue for the year rose 68 percent to $2.1 million, due to new subscriptions to its DeltaBase gene function database.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.